Cargando…

The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Albumin to gamma-glutamyltransferase ratio (AGR) is a newly developed biomarker for the prediction of patients' prognosis in solid tumors. The purpose of the study was to establish a novel AGR-based nomogram to predict tumor prognosis in patients with early-stage HCC undergoing radiofrequency a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenfeng, Zhang, Feng, Quan, Bing, Li, Miao, Lu, Shenxin, Li, Jinghuan, Chen, Rongxin, Yin, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626189/ https://www.ncbi.nlm.nih.gov/pubmed/34840628 http://dx.doi.org/10.1155/2021/3514827

Ejemplares similares

Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model
por: Quan, Bing, et al.
Publicado: (2022)

A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR)
por: Shen, Junyi, et al.
Publicado: (2019)

Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2016)

Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies
por: Wang, Q., et al.
Publicado: (2019)

Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma
por: Zhang, Feng, et al.
Publicado: (2020)

First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Liu, Wenfeng, et al.
Publicado: (2021)

Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
por: Li, Shuo, et al.
Publicado: (2019)

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
por: Lu, Liang-He, et al.
Publicado: (2020)

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment
por: Zhang, Feng, et al.
Publicado: (2022)

Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment
por: Hu, Keshu, et al.
Publicado: (2021)

A Novel Prognostic Scoring Model Based on Albumin and γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis
por: Wang, Liguang, et al.
Publicado: (2019)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Dan, Jiaqiang, et al.
Publicado: (2013)

Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
por: Shen, Yanjun, et al.
Publicado: (2019)

Genetically elevated gamma-glutamyltransferase and Alzheimer's disease
por: Kunutsor, Setor K., et al.
Publicado: (2018)

Serum Gamma-glutamyltransferase and Obesity: is there a Link?
por: Coku, Viko, et al.
Publicado: (2018)

Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes
por: Han, Eugene, et al.
Publicado: (2020)

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Sun, Ping, et al.
Publicado: (2019)

Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2019)

Gamma-Glutamyltransferase and Cancer Incidence: The Ohsaki Cohort Study
por: Tsuboya, Toru, et al.
Publicado: (2012)

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma
por: Wen, Yue-Feng, et al.
Publicado: (2017)

Prognostic Significance of Preoperative Gamma-Glutamyltransferase to Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients with Curative Liver Resection: A Retrospective Cohort Study
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Serum Gamma - Glutamyltransferase Is Associated with Albuminuria: A Population-Based Study
por: Sun, Kan, et al.
Publicado: (2014)

Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection
por: Wang, Jin-Ju, et al.
Publicado: (2020)

Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer
por: Su, Shiqiang, et al.
Publicado: (2021)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
por: Chen, Jinbin, et al.
Publicado: (2018)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Gamma-Glutamyltransferase Fractions in Human Plasma and Bile: Characteristic and Biogenesis
por: Fornaciari, Irene, et al.
Publicado: (2014)

Association of serum gamma-glutamyltransferase and premature coronary artery disease
por: Sheikh, M., et al.
Publicado: (2017)

Investigation of high gamma‐glutamyltransferase syndrome in California Thoroughbred racehorses
por: Peng, Sichong, et al.
Publicado: (2022)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
por: Ma, Hui, et al.
Publicado: (2021)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Kim, Chang Gon, et al.
Publicado: (2019)

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy
por: Yuri, Yukihisa, et al.
Publicado: (2017)

Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
por: Huang, Hao, et al.
Publicado: (2017)

Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection
por: Zhou, Bo, et al.
Publicado: (2017)

Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma
por: Chen, Kai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r4imbancafhkjl1f2ifv4b0q94